247 related articles for article (PubMed ID: 7797612)
1. TAP2 polymorphisms in Australian multiple sclerosis patients.
Bennetts BH; Teutsch SM; Heard RN; Dunckley H; Stewart GJ
J Neuroimmunol; 1995 Jun; 59(1-2):113-21. PubMed ID: 7797612
[TBL] [Abstract][Full Text] [Related]
2. Strong linkage disequilibrium of TAP1*0301 and TAP2D alleles with the HLA A1-B35-DRB1*1104-DQA1*0103-DQB1*0603 extended haplotype in Ashkenazi Jews.
Mora B; Battat S; Grillo R; Safirman C; Israel S; Brautbar C; Mazzilli MC
Eur J Immunogenet; 1999 Oct; 26(5):331-5. PubMed ID: 10553498
[TBL] [Abstract][Full Text] [Related]
3. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus.
Caillat-Zucman S; Daniel S; Djilali-Saiah I; Timsit J; Garchon HJ; Boitard C; Bach JF
Hum Immunol; 1995 Oct; 44(2):80-7. PubMed ID: 8847232
[TBL] [Abstract][Full Text] [Related]
4. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
[TBL] [Abstract][Full Text] [Related]
5. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
6. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis.
Moins-Teisserenc H; Semana G; Alizadeh M; Loiseau P; Bobrynina V; Deschamps I; Edan G; Birebent B; Genetet B; Sabouraud O
Hum Immunol; 1995 Mar; 42(3):195-202. PubMed ID: 7759306
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ and TAP2 genes in patients with insulin-dependent diabetes mellitus.
Lotfi M; Sastry A; Ye M; VanderMeulen J; Dosch HM; Singal DP
Immunol Lett; 1994 Jul; 41(2-3):201-4. PubMed ID: 8002038
[TBL] [Abstract][Full Text] [Related]
8. Is TAP2*0102 allele involved in insulin-dependent diabetes mellitus (type 1) protection?
Cesari M; Hoarau JJ; Caillens H; Robert C; Rouch C; Cadet F; Pabion M
Hum Immunol; 2004 Aug; 65(8):783-93. PubMed ID: 15336779
[TBL] [Abstract][Full Text] [Related]
9. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.
Esposito L; Lampasona V; Bosi E; Poli F; Ferrari M; Bonifacio E
Diabetologia; 1995 Aug; 38(8):968-74. PubMed ID: 7589884
[TBL] [Abstract][Full Text] [Related]
10. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients.
Stewart GJ; Teutsch SM; Castle M; Heard RN; Bennetts BH
Eur J Immunogenet; 1997 Apr; 24(2):81-92. PubMed ID: 9104579
[TBL] [Abstract][Full Text] [Related]
12. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjögren's syndrome.
Anaya JM; Correa PA; Mantilla RD; Arcos-Burgos M
Semin Arthritis Rheum; 2002 Jun; 31(6):396-405. PubMed ID: 12077712
[TBL] [Abstract][Full Text] [Related]
13. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
14. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
[TBL] [Abstract][Full Text] [Related]
15. Comparison of TAP2 frequencies in type 1 diabetes patients and healthy controls from three ethnic groups indicates an African origin for the TAP2 G allele.
Hoarau JJ; Cesari M; Dieye A; Kotea N; Surrun SK; Moine A; Caillens H; Cadet F; Pabion M
Eur J Immunogenet; 2003 Jun; 30(3):207-11. PubMed ID: 12786999
[TBL] [Abstract][Full Text] [Related]
16. Associations between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility.
Tighe MR; Hall MA; Cardi E; Ashkenazi A; Lanchbury JS; Ciclitira PJ
Hum Immunol; 1994 Jan; 39(1):9-16. PubMed ID: 8181966
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.
Martín-Villa JM; Martínez-Laso J; Moreno-Pelayo MA; Castro-Panete MJ; Martínez-Quiles N; Alvarez M; de Juan MD; Gómez-Reino JJ; Arnaiz-Villena A
Ann Rheum Dis; 1998 Apr; 57(4):214-9. PubMed ID: 9709177
[TBL] [Abstract][Full Text] [Related]
18. Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection.
Kuzushita N; Hayashi N; Kanto T; Takehara T; Tatsumi T; Katayama K; Ohkawa K; Ito A; Kasahara A; Moribe T; Sasaki Y; Hori M
Gastroenterology; 1999 May; 116(5):1149-54. PubMed ID: 10220507
[TBL] [Abstract][Full Text] [Related]
19. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
[TBL] [Abstract][Full Text] [Related]
20. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis.
Fakler JW; Schmitt-Egenolf M; Vejbaesya S; Boehncke WH; Sterry W; Eiermann TH
Hum Immunol; 1994 Aug; 40(4):299-302. PubMed ID: 8002377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
